Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dieny… Grant US-11938101-B2 United States of America 26 Mar 2024
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant US-11840497-B2 United States of America 12 Dec 2023
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone… Grant US-11680034-B2 United States of America 20 Jun 2023
Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening Grant US-11366104-B2 United States of America 21 Jun 2022
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclo… Grant US-11304914-B2 United States of America 19 Apr 2022
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions… Grant US-11021424-B2 United States of America 01 Jun 2021
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone… Grant US-10981855-B2 United States of America 20 Apr 2021
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant US-10968166-B2 United States of America 06 Apr 2021
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclo… Grant US-10751302-B2 United States of America 25 Aug 2020
Treatment of pervasive developmental disorders with redox-active therapeutics Grant US-10736857-B2 United States of America 11 Aug 2020
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone… Grant US-10703701-B2 United States of America 07 Jul 2020
Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening Grant US-10627392-B2 United States of America 21 Apr 2020
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclo… Grant US-10251847-B2 United States of America 09 Apr 2019
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant US-10167251-B2 United States of America 01 Jan 2019
Treatment of pervasive developmental disorders with redox-active therapeutics Grant US-10105325-B2 United States of America 23 Oct 2018
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases… Grant US-9932286-B2 United States of America 03 Apr 2018
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress… Grant US-9868711-B2 United States of America 16 Jan 2018
Biomarker for determining mitochondrial damage in friedreich's ataxia Grant US-9733258-B2 United States of America 15 Aug 2017
Resorufin derivatives for treatment of oxidative stress disorders Grant US-9670170-B2 United States of America 06 Jun 2017
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant US-9546132-B2 United States of America 17 Jan 2017
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases Grant US-9486435-B2 United States of America 08 Nov 2016
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions… Grant US-9447006-B2 United States of America 20 Sep 2016
Treatment of pervasive developmental disorders with redox-active therapeutics Grant US-9399612-B2 United States of America 26 Jul 2016
Resorufin derivatives for treatment of oxidative stress disorders Grant US-9296712-B2 United States of America 29 Mar 2016
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases… Grant US-9278085-B2 United States of America 08 Mar 2016
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant US-9169196-B2 United States of America 27 Oct 2015
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Grant US-9090576-B2 United States of America 28 Jul 2015
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress… Grant US-9073873-B2 United States of America 07 Jul 2015
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases Grant US-8952071-B2 United States of America 10 Feb 2015
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Grant US-8716527-B2 United States of America 06 May 2014
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress… Grant US-8716486-B2 United States of America 06 May 2014
TREATMENT OF METHYLMALONIC ACIDURIA, ISOVALERIC ACIDURIA, AND OTHER ORGANIC ACIDURIAS… Application WO-2013006737-A1 World Intellectual Property Organisation (WIPO) 10 Jan 2013
TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES Application WO-2011082355-A1 World Intellectual Property Organisation (WIPO) 07 Jul 2011
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and… Grant US-7432305-B2 United States of America 07 Oct 2008